Here is a list of firms/products that have received FDA regenerative medicine advanced therapy designation or RMAT.
It was updated as of January 10, 2018 with 12 total.
- Asterias (AST-OPC1, spinal cord injury)
- Athersys (MultiStem)
- BlueBird Bio (Lentiglobin in SCID, scroll down to page 3)
- Enzyvant (DiGeorge syndrome)
- Fortress Biotech (Cellvation’s CEVA101, traumatic brain injury)
- Humacyte (Vascular Access for Hemodialysis)
- jCyte (Retinitis Pigmentosa)
- Juno (JCAR017; CAR-T)
- Kiadis Pharma (ATIR101, blood disorders)
- Mallinckrodt/Stratatech’s Stratagraft
- Mesoblast (Heart Failure, mesenchymal precursor cell therapy)
- Vericel Ixmyelocel-T